Tech Company Financing Transactions
Novocardia Funding Round
On 6/29/2021, Novocardia announced $53.7 million in Series A funding from Deerfield Capital and private investors.
Transaction Overview
Company Name
Announced On
6/29/2021
Transaction Type
Venture Equity
Amount
$53,700,000
Round
Series A
Investors
Deerfield Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to build out its care delivery network of cardiology practices, develop its proprietary actuarial and quality-focused analytics platform and deploy its cardiovascular disease care model.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
345 Park Ave. South 12th Floor
New York, NY 10010
USA
New York, NY 10010
USA
Phone
Website
Email Address
Overview
At Novocardia, we understand the devastating effects cardiovascular disease has on our country. Our founders created our company to provide cardiologists with the resources to more effectively deliver high-quality care to the people who desperately need it.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Blumenthal
Chief Financial Officer
Nick Satey
Chief Marketing Officer
Kathryn Hughes
Chief Medical Officer
Julius Torelli
Vice President
Brooks Pollard
VP - Administration
Benjamin Diestel
VP - Bus. Development
Geoff Wade
VP - General Counsel
Christopher Richardson
VP - Human Resources
Kiesha Mayes
Browse more venture capital transactions:
Prev: 6/29/2021: Botrista Technology venture capital transaction
Next: 6/29/2021: Alto venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs